New Jersey A 3394: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2018-02-15)

State: New Jersey · Session: 218 · Bill: A 3394

Subjects: DISEASE, PHARMACEUTIC

Sponsors: McGuckin, Gregory P.

View New Jersey A 3394 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.